8-KLeadership ChangesExhibits & Filings

Expedia Group, Inc. 8-K Report, Executive Changes (Mar 7, 2018)

Filed March 7, 2018For Securities:EXPE

Summary

Expedia Group, Inc. (EXPE) filed an 8-K on March 7, 2018, detailing an amended and restated employment agreement for its Chief Legal Officer and Secretary, Robert Dzielak, effective March 3, 2018. The agreement includes a salary increase to $700,000 annually, maintaining a target bonus of 100% of base salary. Key provisions include severance benefits upon termination without cause or resignation for good reason, such as continued base salary for 12-18 months and accelerated vesting of certain equity awards. The company also granted Mr. Dzielak a significant equity package, including restricted stock units and stock options, some of which are performance-based with substantial stock price hurdles. These changes reflect a renegotiation of Mr. Dzielak's compensation and employment terms, aligning his incentives with potential future stock performance. Investors should note the increased base salary and the comprehensive severance package, which provides financial security in certain termination scenarios. The performance-based options, requiring significant stock price appreciation, indicate a focus on driving long-term shareholder value.

Key Highlights

  • 1Amended and restated employment agreement for Chief Legal Officer, Robert Dzielak, effective March 3, 2018.
  • 2Annual base salary increased from $600,000 to $700,000, effective February 26, 2018.
  • 3Target bonus remains unchanged at 100% of base salary.
  • 4Severance package includes up to 18 months of base salary continuation and 12 months of COBRA payment upon termination without cause or for good reason.
  • 5Accelerated vesting for a portion of equity awards (RSUs and options) upon qualifying termination.
  • 6Significant equity grants include 12,747 RSUs vesting over four years, and substantial stock options, including performance-based options with stock price targets of $200 and $180.
  • 7Restated employment agreement includes restrictive covenants related to competition and employee solicitation for the duration of the salary continuation period.

Frequently Asked Questions

The primary changes include an increase in his annual base salary to $700,000 and the establishment of a new severance package. This package provides for continued base salary payments for 12 to 18 months and continued health insurance coverage for 12 months in the event of termination without cause or resignation for good reason. Additionally, certain equity awards will accelerate under these termination conditions.

Mr. Dzielak received a grant of 12,747 restricted stock units (RSUs) that vest annually over four years. He also received various stock options: some vest annually over four years, others have cliff vesting schedules, and a portion are performance-based options tied to achieving specific stock prices ($200 and $180) on certain dates. All stock options have an exercise price of $104.50 and a seven-year term.

The performance-based options have specific stock price hurdles: 50% are subject to a stock price goal of $200, and 50% are subject to a stock price goal of $180, both to be met on specific dates in September 2021. These stock price goals represent significant increases from the stock's closing price on the grant date. The achievement of these goals is measured by the average closing stock price over a six or twelve-month period prior to the vesting date.

For shareholders, this filing highlights the company's commitment to retaining key executive talent and aligning executive compensation with long-term stock performance. The increase in base salary is a direct cost, while the performance-based equity awards incentivize significant stock price appreciation. The severance provisions provide a safety net for the executive but also represent potential future costs for the company under specific termination scenarios.